# Attovia Therapeutics (ATTO) — News

ATTO · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/atto/news

## Recent headlines

- [Trading released/resumed: (Attiu) Reason not available](https://www.ainvest.com/news/trading-released-resumed-attiu-reason-2610) — AInvest Wire, Oct 13, 2026
  Trading in the security known as "Attiu" has been temporarily halted, with the resumption date and reason for the halt not currently available to the public. Trading pauses are typically implemented to address market irregularities, ensure fair trading practices, or allow for dissemination of…
- [Attovia Therapeutics - Q2 collaboration revenue was $0.50 mln](https://www.ainvest.com/news/attovia-therapeutics-q2-collaboration-revenue-0-50-mln-2609) — AInvest Wire, Sep 2, 2026
- [Attovia Therapeutics Inc: Leerink Partners initiates coverage with outperform rating; target price $52](https://www.ainvest.com/news/attovia-therapeutics-leerink-partners-initiates-coverage-outperform-rating-target-price-52-2608) — AInvest Wire, Aug 31, 2026
  Leerink Partners has initiated coverage on Attovia Therapeutics Inc (Nasdaq: ATTO) with an "Outperform" rating and a target price of $52 per share, reinforcing positive sentiment toward the clinical-stage biopharmaceutical company. This follows Attovia’s successful upsized initial public offering…
- [Atovia Therapeutics upsized $17M-shr IPO prices at $17/shr](https://www.ainvest.com/news/atovia-therapeutics-upsized-17m-shr-ipo-prices-17-shr-2608) — AInvest Wire, Aug 5, 2026
  Attovia Therapeutics has priced its upsized initial public offering (IPO) at $17 per share, raising a total of $289 million based on the 17 million shares offered. This represents an increase from the previously targeted $17 million valuation, reflecting strong investor interest in the…
- [Attovia Therapeutics seeks up to $289M in IPO, saw $212.5M](https://www.ainvest.com/news/attovia-therapeutics-seeks-289m-ipo-212-5m-2608) — AInvest Wire, Aug 4, 2026

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).